Hong Kong · Delayed Price · Currency is HKD Xuanzhu Biopharmaceutical Statistics
Total Valuation
HKG:2575 has a market cap or net worth of HKD 4.45 billion. The enterprise value is 3.87 billion.
| Market Cap | 4.45B |
| Enterprise Value | 3.87B |
Important Dates
The next estimated earnings date is Thursday, November 26, 2026.
| Earnings Date | Nov 26, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
HKG:2575 has 517.95 million shares outstanding. The number of shares has increased by 10.62% in one year.
| Current Share Class | 517.95M |
| Shares Outstanding | 517.95M |
| Shares Change (YoY) | +10.62% |
| Shares Change (QoQ) | +8.13% |
| Owned by Insiders (%) | 2.18% |
| Owned by Institutions (%) | 4.56% |
| Float | 120.75M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 37.34 |
| PB Ratio | 2.98 |
| P/TBV Ratio | 6.30 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 32.42 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.69, with a Debt / Equity ratio of 0.00.
| Current Ratio | 3.69 |
| Quick Ratio | 2.73 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -1,909.87 |
Financial Efficiency
Return on equity (ROE) is -19.61% and return on invested capital (ROIC) is -11.81%.
| Return on Equity (ROE) | -19.61% |
| Return on Assets (ROA) | -9.68% |
| Return on Invested Capital (ROIC) | -11.81% |
| Return on Capital Employed (ROCE) | -15.05% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | 346,744 |
| Profits Per Employee | -704,564 |
| Employee Count | 344 |
| Asset Turnover | 0.08 |
| Inventory Turnover | 1.04 |
Taxes
In the past 12 months, HKG:2575 has paid 6,927 in taxes.
| Income Tax | 6,927 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -86.36% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -86.36% |
| 50-Day Moving Average | 9.08 |
| 200-Day Moving Average | 27.01 |
| Relative Strength Index (RSI) | 48.55 |
| Average Volume (20 Days) | 1,515,246 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, HKG:2575 had revenue of HKD 119.28 million and -242.37 million in losses. Loss per share was -0.49.
| Revenue | 119.28M |
| Gross Profit | 35.61M |
| Operating Income | -233.72M |
| Pretax Income | -242.36M |
| Net Income | -242.37M |
| EBITDA | -199.46M |
| EBIT | -233.72M |
| Loss Per Share | -0.49 |
Balance Sheet
The company has 587.01 million in cash and 251,675 in debt, with a net cash position of 586.76 million or 1.13 per share.
| Cash & Cash Equivalents | 587.01M |
| Total Debt | 251,675 |
| Net Cash | 586.76M |
| Net Cash Per Share | 1.13 |
| Equity (Book Value) | 1.49B |
| Book Value Per Share | 2.89 |
| Working Capital | 632.80M |
Cash Flow
In the last 12 months, operating cash flow was -218.95 million and capital expenditures -907,415, giving a free cash flow of -219.86 million.
| Operating Cash Flow | -218.95M |
| Capital Expenditures | -907,415 |
| Depreciation & Amortization | 34.97M |
| Net Borrowing | -1.04M |
| Free Cash Flow | -219.86M |
| FCF Per Share | -0.42 |
Margins
Gross margin is 29.85%, with operating and profit margins of -195.94% and -203.19%.
| Gross Margin | 29.85% |
| Operating Margin | -195.94% |
| Pretax Margin | -203.19% |
| Profit Margin | -203.19% |
| EBITDA Margin | -167.22% |
| EBIT Margin | -195.94% |
| FCF Margin | n/a |
Dividends & Yields
HKG:2575 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -10.62% |
| Shareholder Yield | -10.62% |
| Earnings Yield | -5.65% |
| FCF Yield | -4.94% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
HKG:2575 has an Altman Z-Score of 49.43 and a Piotroski F-Score of 2.
| Altman Z-Score | 49.43 |
| Piotroski F-Score | 2 |